 | • レポートコード：MRC2Q12-16812 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、爪真菌症治療法のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 爪真菌症治療法のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 爪真菌症治療法の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 爪真菌症治療法のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの爪真菌症治療法の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の爪真菌症治療法の売上および2028年までの予測に焦点を当てています。 爪真菌症治療法のグローバル主要企業には、Bausch Health、Bayer、Cipla、Dr Reddys Laboratories、Galderma、Johnson and Johnson、Lumenis、Medimetriks、Moberg Pharma、Novartis、Pfizerなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 爪真菌症治療法市場は、タイプとアプリケーションによって区分されます。世界の爪真菌症治療法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 薬物療法、レーザー療法、光線力学療法 【アプリケーション別セグメント】 総合病院、専門クリニック 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 爪真菌症治療法製品概要 - タイプ別市場（薬物療法、レーザー療法、光線力学療法） - アプリケーション別市場（総合病院、専門クリニック） - 調査の目的 ・エグゼクティブサマリー - 世界の爪真菌症治療法販売量予測2017-2028 - 世界の爪真菌症治療法売上予測2017-2028 - 爪真菌症治療法の地域別販売量 - 爪真菌症治療法の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別爪真菌症治療法販売量 - 主要メーカー別爪真菌症治療法売上 - 主要メーカー別爪真菌症治療法価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（薬物療法、レーザー療法、光線力学療法） - 爪真菌症治療法のタイプ別販売量 - 爪真菌症治療法のタイプ別売上 - 爪真菌症治療法のタイプ別価格 ・アプリケーション別市場規模（総合病院、専門クリニック） - 爪真菌症治療法のアプリケーション別販売量 - 爪真菌症治療法のアプリケーション別売上 - 爪真菌症治療法のアプリケーション別価格 ・北米市場 - 北米の爪真菌症治療法市場規模（タイプ別、アプリケーション別） - 主要国別の爪真菌症治療法市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの爪真菌症治療法市場規模（タイプ別、アプリケーション別） - 主要国別の爪真菌症治療法市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の爪真菌症治療法市場規模（タイプ別、アプリケーション別） - 主要国別の爪真菌症治療法市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の爪真菌症治療法市場規模（タイプ別、アプリケーション別） - 主要国別の爪真菌症治療法市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの爪真菌症治療法市場規模（タイプ別、アプリケーション別） - 主要国別の爪真菌症治療法市場規模（トルコ、サウジアラビア） ・企業情報 Bausch Health、Bayer、Cipla、Dr Reddys Laboratories、Galderma、Johnson and Johnson、Lumenis、Medimetriks、Moberg Pharma、Novartis、Pfizer ・産業チェーン及び販売チャネル分析 - 爪真菌症治療法の産業チェーン分析 - 爪真菌症治療法の原材料 - 爪真菌症治療法の生産プロセス - 爪真菌症治療法の販売及びマーケティング - 爪真菌症治療法の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 爪真菌症治療法の産業動向 - 爪真菌症治療法のマーケットドライバー - 爪真菌症治療法の課題 - 爪真菌症治療法の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Onychomycosis Treatment Technique estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Onychomycosis Treatment Technique is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Onychomycosis Treatment Technique is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Onychomycosis Treatment Technique is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Onychomycosis Treatment Technique include Bausch Health, Bayer, Cipla, Dr Reddys Laboratories, Galderma, Johnson and Johnson, Lumenis, Medimetriks and Moberg Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Onychomycosis Treatment Technique companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Onychomycosis Treatment Technique market. Further, it explains the major drivers and regional dynamics of the global Onychomycosis Treatment Technique market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Bausch Health
Bayer
Cipla
Dr Reddys Laboratories
Galderma
Johnson and Johnson
Lumenis
Medimetriks
Moberg Pharma
Novartis
Pfizer
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Onychomycosis Treatment Technique Segment by Type
Drug Therapy
Laser Therapy
Photodynamic Therapy
Onychomycosis Treatment Technique Segment by Application
General Hospitals
Specialty Clinics
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Onychomycosis Treatment Technique market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Onychomycosis Treatment Technique market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Onychomycosis Treatment Technique, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Onychomycosis Treatment Technique, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Onychomycosis Treatment Technique revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Onychomycosis Treatment Technique market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Onychomycosis Treatment Technique revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bausch Health, Bayer, Cipla, Dr Reddys Laboratories, Galderma, Johnson and Johnson, Lumenis, Medimetriks and Moberg Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Onychomycosis Treatment Technique in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Onychomycosis Treatment Technique companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Onychomycosis Treatment Technique revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Onychomycosis Treatment Technique Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drug Therapy
1.2.3 Laser Therapy
1.2.4 Photodynamic Therapy
1.3 Market by Application
1.3.1 Global Onychomycosis Treatment Technique Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Onychomycosis Treatment Technique Market Perspective (2017-2028)
2.2 Onychomycosis Treatment Technique Growth Trends by Region
2.2.1 Onychomycosis Treatment Technique Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Onychomycosis Treatment Technique Historic Market Size by Region (2017-2022)
2.2.3 Onychomycosis Treatment Technique Forecasted Market Size by Region (2023-2028)
2.3 Onychomycosis Treatment Technique Market Dynamics
2.3.1 Onychomycosis Treatment Technique Industry Trends
2.3.2 Onychomycosis Treatment Technique Market Drivers
2.3.3 Onychomycosis Treatment Technique Market Challenges
2.3.4 Onychomycosis Treatment Technique Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Onychomycosis Treatment Technique Players by Revenue
3.1.1 Global Top Onychomycosis Treatment Technique Players by Revenue (2017-2022)
3.1.2 Global Onychomycosis Treatment Technique Revenue Market Share by Players (2017-2022)
3.2 Global Onychomycosis Treatment Technique Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Onychomycosis Treatment Technique Revenue
3.4 Global Onychomycosis Treatment Technique Market Concentration Ratio
3.4.1 Global Onychomycosis Treatment Technique Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Onychomycosis Treatment Technique Revenue in 2021
3.5 Onychomycosis Treatment Technique Key Players Head office and Area Served
3.6 Key Players Onychomycosis Treatment Technique Product Solution and Service
3.7 Date of Enter into Onychomycosis Treatment Technique Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Onychomycosis Treatment Technique Breakdown Data by Type
4.1 Global Onychomycosis Treatment Technique Historic Market Size by Type (2017-2022)
4.2 Global Onychomycosis Treatment Technique Forecasted Market Size by Type (2023-2028)
5 Onychomycosis Treatment Technique Breakdown Data by Application
5.1 Global Onychomycosis Treatment Technique Historic Market Size by Application (2017-2022)
5.2 Global Onychomycosis Treatment Technique Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Onychomycosis Treatment Technique Market Size (2017-2028)
6.2 North America Onychomycosis Treatment Technique Market Size by Type
6.2.1 North America Onychomycosis Treatment Technique Market Size by Type (2017-2022)
6.2.2 North America Onychomycosis Treatment Technique Market Size by Type (2023-2028)
6.2.3 North America Onychomycosis Treatment Technique Market Share by Type (2017-2028)
6.3 North America Onychomycosis Treatment Technique Market Size by Application
6.3.1 North America Onychomycosis Treatment Technique Market Size by Application (2017-2022)
6.3.2 North America Onychomycosis Treatment Technique Market Size by Application (2023-2028)
6.3.3 North America Onychomycosis Treatment Technique Market Share by Application (2017-2028)
6.4 North America Onychomycosis Treatment Technique Market Size by Country
6.4.1 North America Onychomycosis Treatment Technique Market Size by Country (2017-2022)
6.4.2 North America Onychomycosis Treatment Technique Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Onychomycosis Treatment Technique Market Size (2017-2028)
7.2 Europe Onychomycosis Treatment Technique Market Size by Type
7.2.1 Europe Onychomycosis Treatment Technique Market Size by Type (2017-2022)
7.2.2 Europe Onychomycosis Treatment Technique Market Size by Type (2023-2028)
7.2.3 Europe Onychomycosis Treatment Technique Market Share by Type (2017-2028)
7.3 Europe Onychomycosis Treatment Technique Market Size by Application
7.3.1 Europe Onychomycosis Treatment Technique Market Size by Application (2017-2022)
7.3.2 Europe Onychomycosis Treatment Technique Market Size by Application (2023-2028)
7.3.3 Europe Onychomycosis Treatment Technique Market Share by Application (2017-2028)
7.4 Europe Onychomycosis Treatment Technique Market Size by Country
7.4.1 Europe Onychomycosis Treatment Technique Market Size by Country (2017-2022)
7.4.2 Europe Onychomycosis Treatment Technique Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Onychomycosis Treatment Technique Market Size (2017-2028)
8.2 Asia-Pacific Onychomycosis Treatment Technique Market Size by Type
8.2.1 Asia-Pacific Onychomycosis Treatment Technique Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Onychomycosis Treatment Technique Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Onychomycosis Treatment Technique Market Share by Type (2017-2028)
8.3 Asia-Pacific Onychomycosis Treatment Technique Market Size by Application
8.3.1 Asia-Pacific Onychomycosis Treatment Technique Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Onychomycosis Treatment Technique Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Onychomycosis Treatment Technique Market Share by Application (2017-2028)
8.4 Asia-Pacific Onychomycosis Treatment Technique Market Size by Region
8.4.1 Asia-Pacific Onychomycosis Treatment Technique Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Onychomycosis Treatment Technique Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Onychomycosis Treatment Technique Market Size (2017-2028)
9.2 Latin America Onychomycosis Treatment Technique Market Size by Type
9.2.1 Latin America Onychomycosis Treatment Technique Market Size by Type (2017-2022)
9.2.2 Latin America Onychomycosis Treatment Technique Market Size by Type (2023-2028)
9.2.3 Latin America Onychomycosis Treatment Technique Market Share by Type (2017-2028)
9.3 Latin America Onychomycosis Treatment Technique Market Size by Application
9.3.1 Latin America Onychomycosis Treatment Technique Market Size by Application (2017-2022)
9.3.2 Latin America Onychomycosis Treatment Technique Market Size by Application (2023-2028)
9.3.3 Latin America Onychomycosis Treatment Technique Market Share by Application (2017-2028)
9.4 Latin America Onychomycosis Treatment Technique Market Size by Country
9.4.1 Latin America Onychomycosis Treatment Technique Market Size by Country (2017-2022)
9.4.2 Latin America Onychomycosis Treatment Technique Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Onychomycosis Treatment Technique Market Size (2017-2028)
10.2 Middle East & Africa Onychomycosis Treatment Technique Market Size by Type
10.2.1 Middle East & Africa Onychomycosis Treatment Technique Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Onychomycosis Treatment Technique Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Onychomycosis Treatment Technique Market Share by Type (2017-2028)
10.3 Middle East & Africa Onychomycosis Treatment Technique Market Size by Application
10.3.1 Middle East & Africa Onychomycosis Treatment Technique Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Onychomycosis Treatment Technique Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Onychomycosis Treatment Technique Market Share by Application (2017-2028)
10.4 Middle East & Africa Onychomycosis Treatment Technique Market Size by Country
10.4.1 Middle East & Africa Onychomycosis Treatment Technique Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Onychomycosis Treatment Technique Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Onychomycosis Treatment Technique Introduction
11.1.4 Bausch Health Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.1.5 Bausch Health Recent Developments
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Onychomycosis Treatment Technique Introduction
11.2.4 Bayer Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.2.5 Bayer Recent Developments
11.3 Cipla
11.3.1 Cipla Company Details
11.3.2 Cipla Business Overview
11.3.3 Cipla Onychomycosis Treatment Technique Introduction
11.3.4 Cipla Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.3.5 Cipla Recent Developments
11.4 Dr Reddys Laboratories
11.4.1 Dr Reddys Laboratories Company Details
11.4.2 Dr Reddys Laboratories Business Overview
11.4.3 Dr Reddys Laboratories Onychomycosis Treatment Technique Introduction
11.4.4 Dr Reddys Laboratories Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.4.5 Dr Reddys Laboratories Recent Developments
11.5 Galderma
11.5.1 Galderma Company Details
11.5.2 Galderma Business Overview
11.5.3 Galderma Onychomycosis Treatment Technique Introduction
11.5.4 Galderma Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.5.5 Galderma Recent Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Details
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Onychomycosis Treatment Technique Introduction
11.6.4 Johnson and Johnson Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.6.5 Johnson and Johnson Recent Developments
11.7 Lumenis
11.7.1 Lumenis Company Details
11.7.2 Lumenis Business Overview
11.7.3 Lumenis Onychomycosis Treatment Technique Introduction
11.7.4 Lumenis Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.7.5 Lumenis Recent Developments
11.8 Medimetriks
11.8.1 Medimetriks Company Details
11.8.2 Medimetriks Business Overview
11.8.3 Medimetriks Onychomycosis Treatment Technique Introduction
11.8.4 Medimetriks Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.8.5 Medimetriks Recent Developments
11.9 Moberg Pharma
11.9.1 Moberg Pharma Company Details
11.9.2 Moberg Pharma Business Overview
11.9.3 Moberg Pharma Onychomycosis Treatment Technique Introduction
11.9.4 Moberg Pharma Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.9.5 Moberg Pharma Recent Developments
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Onychomycosis Treatment Technique Introduction
11.10.4 Novartis Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.10.5 Novartis Recent Developments
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Onychomycosis Treatment Technique Introduction
11.11.4 Pfizer Revenue in Onychomycosis Treatment Technique Business (2017-2022)
11.11.5 Pfizer Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer